Haddow JE, McClain MR, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME: Variability in thyroid stimulating hormone suppression by human chorionic gonadotropin during early pregnancy. J Clin Endocrinol Metab, 93:3341-3347, 2008.

Haddow JE, Palomaki GE, Canick JA, Knight GJ: Prenatal screening for open neural tube defects and Down’s syndrome. In: Fetal Medicine: Basic Science and Clinical Practice. Rodeck CH, Whittle MJ (eds), Churchill Livingstone: London, pp. 243-264, 2009.

Kavsak PA, Ko DT, Newman AM, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: “Upstream markers” provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clin Chim Acta, 387:133-138, 2008.

Kavsak PA, Ko DT, Newman AM, Lustig V, Palomaki GE, MacRae AR, Jaffe AS: Vascular versus myocardial dysfunction in acute coronary syndrome: Are the adhesion molecules as powerful as NT-proBNP for long-term risk stratification? Clin Biochem, 41:436-439, 2008.

Kavsak PA, Newman AM, Ko DT, Palomaki GE, Lustig V, MacRae AR, Jaffe AS: Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms? Clin Chem, 54:747-751, 2008.

Lambert-Messerlian GM, McClain MR, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME; FaSTER Consortium: First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol, 199:62.e1-6, 2008.

Lambert-Messerlian GM, Palomaki GE, Canick JA: Inhibin A measurement using an automated assay platform. Prenat Diagn, 28:399-403, 2008.

McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME: FaSTER Research Consortium: Sequential first- and second-trimester TSH, free Thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol, 199:129e1-129.e6, 2008.

McClain MR, Palomaki GE, Haddow JE: An Abbreviated ACCE Review of BMPR2 Mutation Testing Among Individuals Diagnosed with Familial or Idiopathic Pulmonary Arterial Hypertension.

McClain MR, Palomaki GE, Piper M, Haddow JE: A Rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding. Genet Med, 10:89-98, 2008.

McClain MR, Palomaki GE, Hampel H, Westman JA, Haddow JE: Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women. Fam Cancer, 7:341-345, 2008.

Monaghan KG, Feldman GL, Palomaki GE, Spector EB; Ashkenazi Jewish Reproductive Screening Working Group; Molecular Subcommittee of the ACMG Laboratory Quality Assurance Committee: Technical standards and guidelines for reproductive screening in the Ashkenazi Jewish population. Genet Med, 10:57-72, 2008.

Palomaki GE, Neveux LM, Donnenfeld A, Lee JE, McDowell G, Canick JA, Summers A, Lambert-Messerlian G, Kellner LH, Zebelman A, Haddow JE: Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective. Genet Med, 10:131-138, 2008.

Urato AC, Peter I, Canick J, Lambert-Messerlian G, Pulkkinen A, Knight G, Jeong YJ, Johnson KL, Bianchi DW: Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels. Prenat Diagn, 28:186-190, 2008.